Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-23

FDA Approved: WARFARIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Warfarin sodium submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WARFARIN SODIUM (Warfarin sodium)

Snippet

SUPPL AP for WARFARIN SODIUM (WARFARIN)